Monday, May 04, 2020 7:59:24 AM
Hi Horseb4Cart,
If the company sells shares ( dilution) with an offering, people buy those shares and thus deliver money. They also get free warrants with an exercise price and expiration date.
Friendly people keep the shares AND the warrants OR sell the shares and only keep the free warrants. You see often the pps rises before an offering. So they have a possibility to sell the shares above the price they payed for those.
Not so friendly people sell the shares ( with a profit probably) and keep the warrants. With these warrants as a protection against a sudden event ( BO or Partnership), they can sell another portion of shares.
Those are naked because they actually have no shares to sell. When this protection disappears ( because of expiration date) they lose their protection against a BO or Partnership. Then you get the sqeeze because they have to buy those shorted shares. They have to be delivered to the MM's ( or broker).
If the expiration date is moved to a later date, they still have the protection against BO and they have another few monts ( or years. Depends on). The exercise price stays the same so they can always use this as a protection.
With this extension of NWBO warrants they have more months ( til november).
Only if the broker or MM wants the shorted shares back ( they sold those for them) BEFORE expiration date of the warrants, they have to buy at the open market because they are not allowed to exercise those warrants for shares until november.
And that will be fun for us longs.
But in November they still have the warrants to sell (with a low exercise price and after BO a high pps ).
My opinion ofcourse.
Best to you and all longs.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
